Form 4 for CTVA Corteva
Accepted 2025-11-04 00:00:00 ET · period of report 2025-10-31 · accession 0001193125-25-264847 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 2025-10-31 | CTVA | Giesselman Janet Plaut | Dir | A - Grant | $61.44 | +63.07 | 17.5K | +0.4% | +$3,875 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-31 | A | A | 63.07 | $61.44 | 17,464.90 | D | — | — | (F1) Represents stock units acquired pursuant to the Issuer's Stock Accumulation and Deferred Compensation Plan for Directors under which non-employee directors may elect to defer the payment of all or a specified portion of their cash compensation to be settled in CTVA common stock on a one-for-one basis on a future date selected by the Reporting Person at the time of his or her deferral election. Cash compensation deferred in the form of stock units is calculated based on the closing price of CTVA common stock on the date the cash compensation would have otherwise been payable. (F2) Includes acquisition of 43.4154 shares pursuant to dividend reinvestment. |